Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule while breastfeeding. We will also discuss about common side effects and warnings associated with Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule.

What is Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule ?


Nitrofurantoin capsules, USP (monohydrate/macrocrystals) are indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules, USP (monohydrate/macrocrystals) and other antibacterial drugs, nitrofurantoin capsules, USP (monohydrate/macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with nitrofurantoin capsules, USP (monohydrate/macrocrystals) are predisposed to persistence or reappearance of bacteriuria (see CLINICAL STUDIES ). Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with nitrofurantoin capsules, USP (monohydrate/macrocrystals), other therapeutic agents with broader tissue distribution should be selected. In considering the use of nitrofurantoin capsules, USP (monohydrate/macrocrystals), lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.

Can I use Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule while breastfeeding?

Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule safe for breastfeeding
Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule is primarily made of two things Nitrofurantoin, Nitrofurantoin. What we have done here is we have analyzed Nitrofurantoin for its impact on breastfeeding and analyzed Nitrofurantoin for its impact on breastfeeding. Our analysis of Nitrofurantoin and Nitrofurantoin suggests that Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule is probably safe in breastfeeding however we suggest you to check detail about both below.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Nitrofurantoin has been detected in human breast milk in trace amounts. Because of the potential for serious adverse reactions from nitrofurantoin in nursing infants under one month of age, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother (see CONTRAINDICATIONS ).

Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule Breastfeeding Analsys


Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.

Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.

Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule Breastfeeding Analsys - 2


Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule and breastfeeding

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.

Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.

Is Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule safe while breastfeeding

What should I do if already breastfed my kid after using Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule and have used it then do not panic as Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule is mostly safe in breastfeeding and should not cause any harm to your baby.


My doctor has prescribed me Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule, what should I do?

Usage of Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule is safe for nursing mothers and baby, No worries.


If I am using Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule
Nitrofurantoin Monohydrate/macrocrystals
Nitrofurantion Capsule
Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Capsule
Nitrofurantoin Monohydrate/ Macrocrystalline Capsule
Nitrofurantoin Mono hydrate Capsule
Nitrofurantoin Macrocrystals | Nitrofurantoin Capsule
Nitrofurantoin Suspension
Nitrofurantoin Monohydrate/macrocrystals (monohydrate/macrocrystals)
Macrodantin | Nitrofurantoin Macrocrystals Capsule
Nitrofurantoin Monohydrate/macrocrystalline Capsule